+
Site Tour

N. Van Mieghen "Navitor™ is a device iteration that really has changed the way we do our implantation"

Discover what N. Van Mieghem, M. Van Wely, L. Testa, M. Taramasso and M. Mullen think about Navitor™ stable delivery

Related Videos

Now you've got Navitor.
Future ready.

Now you've got Navitor. Remarkable performance.

TAVI Summit 2023: AS with HF

TAVI Summit - PreTAVR CT analysis

TAVI Summit - Cardiac imaging and morphology

PremiClose 2024: Pediatric cardiologist view

TAVI Summit - TAVR in bicuspid

PremiClose 2024: Nenonatologist view

TAVI Summit 2023: Aortic stenosis

EACVI Summit 2023: Congress symposium

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

PremiClose 2024: Optimizing care

TAVI Summit - Cardiac imaging and morphology

TAVI Summit - Cardiac imaging

Navitor™: Hemodynamics

CONNEXT


HUB
RELATED RESOURCES

Navitor Valve in small aortic annuli

ACC 2023: COAPT™ trial

Epic Mitral – 10-Year Clinical Outcomes

Poster: Primary MR in the Very Elderly

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline